Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tobacco and Nicotine Dependence Vulnerability as a Function of Dopaminergic Dysregulation: Proposing a Novel Strategy to Promote Neurotransmitter Homeostasis.

Current neuropharmacology·2026
Same author

Opioid-Induced Nodding-Not a Nice Nap.

Acta scientific neurology·2026
Same author

Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?

British journal of healthcare and medical research·2026
Same author

Developmental Timing, Substance Exposure, and Persistent Brain Change: Recontextualizing Cannabis, Stimulants, and Opioids Across an Extended Neurodevelopmental Window.

The American journal of psychiatry·2026
Same author

Research Limits on Knowledge of Benefit or Harm of Cannabis and Cannabinoids Use-Reply.

JAMA·2026
Same author

Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.

Current pharmaceutical biotechnology·2026
Same journal

Moderate drinking or abstinence? Exploring the association of drinking status with multimorbidity in China.

Journal of addictive diseases·2026
Same journal

Sequential dual-target tDCS for tobacco use disorder: A longitudinal pilot case series targeting craving and inhibitory control.

Journal of addictive diseases·2026
Same journal

Comparative outcomes of opioid withdrawal management strategy in patients with injection-related bacteremia.

Journal of addictive diseases·2026
Same journal

Wearable physiological signals and relapse status during smoking cessation: a pilot study.

Journal of addictive diseases·2026
Same journal

Admitting powerlessness empowers recovery from substance use disorder: a conceptual model.

Journal of addictive diseases·2026
Same journal

President's message: the perilous illusion of supervised injection sites.

Journal of addictive diseases·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Comorbidity and "self-medication".

Robert L DuPont1, Mark S Gold

  • 1Institute for Behavior and Health, Inc., 6191 Executive Boulevard, Rockville, MD 20852, USA. BobDuPont@aol.com

Journal of Addictive Diseases
|March 17, 2009
PubMed
Summary
This summary is machine-generated.

Substance use disorders often co-occur with other conditions. Misinterpreting drug use as self-medication for these comorbidities hinders effective addiction treatment.

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Related Experiment Videos

Last Updated: Jun 24, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Neuroscience

Background:

  • Comorbidity is prevalent in substance use disorders (SUDs), particularly with non-alcohol drugs.
  • Physicians often incorrectly attribute SUDs to self-medication of comorbid conditions.

Purpose of the Study:

  • To clarify the distinction between nonmedical drug use and therapeutic self-medication in addiction.
  • To advocate for independent and effective treatment of comorbid conditions in SUDs.

Main Methods:

  • Conceptual analysis of addictive behavior and self-medication hypotheses.
  • Review of clinical implications for treating comorbid SUDs.

Main Results:

  • Nonmedical drug use in SUDs primarily seeks brain reward, not symptom relief.
  • Treating comorbid conditions does not automatically resolve addictive drug use.

Conclusions:

  • Each comorbid condition in SUDs should be treated as a distinct, serious illness.
  • Avoid viewing one disorder as a symptom of another; pursue specific, evidence-based treatments for all conditions.